Advertisement
Screener

Xencor, Inc (XNCR) Available-for-sale Securities, Amortized Cost Basis

1.7 / 5 stars · 33/95 Roast Me

Xencor, Inc Available-for-sale Securities, Amortized Cost Basis

Xencor, Inc (XNCR) had Available-for-sale Securities, Amortized Cost Basis of $353.77 million as of 2017-12-31, per its 10-K filed 2018-02-28.

Discontinued › Notes › Investments

us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-02-28

  • 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $353.77M.
  • 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $369.79M.
  • 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $378.81M.
  • 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $391.33M.
Period endAvailable-for-sale Securities, Amortized Cost Basis
2017-12-31$353.77M
10-K · filed 2018-02-28
2017-09-30$369.79M
10-Q · filed 2017-11-08
2017-06-30$378.81M
10-Q · filed 2017-08-07
2017-03-31$391.33M
10-Q · filed 2017-05-10
2016-12-31$402.52M
10-K · filed 2018-02-28
2016-09-30$298.19M
10-Q · filed 2016-11-02
2016-06-30$167.62M
10-Q · filed 2016-08-03
2016-03-31$177.28M
10-Q · filed 2016-05-02
2015-12-31$190.70M
10-K · filed 2017-03-01
2015-09-30$149.75M
10-Q · filed 2015-11-04
2015-06-30$149.47M
10-Q · filed 2015-08-05
2015-03-31$49.89M
10-Q · filed 2015-05-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Septerna, Inc. (SEPN)United States$1.783B-63.01
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
COMPASS Pathways plc (CMPS)$1.812B-4.87
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82